Health benefit for the child and promotion of the common good were the two most important reasons for participation in the FinIP vaccine trial. Issue 31 (17th July 2015)

• Record Type: Journal Article
• Authors: Nieminen, Heta; Syrjänen, Ritva K.; Puumalainen, Taneli; Sirén, Päivi; Palmu, Arto A.
• Is Part Of: Vaccine. Volume 33:Issue 31(2015)
• Page Start: 3695
• Page End: 3702
• Publication Date: 2015-07-17
• Subjects: Vaccines -- Periodicals; 615.372
• DOI: 10.1016/j.vaccine.2015.06.010
• Languages: English
• ISSNs: 0264-410X

Abstract

<abstract abstract-type="author-highlights" id="abs0005"> <title id="sect0005">Highlights</title> <sec> <p id="spar0005"> <list id="lis0005"> <list-item id="lsti0005"> <label></label> <p id="par0005">Health benefit and promotion of the common good were important reasons to consent.</p> </list-item> <list-item id="lsti0010"> <label></label> <p id="par0010">Vaccine safety concerns were the main reason for declining consent.</p> </list-item> <list-item id="lsti0015"> <label></label> <p id="par0015">Double-blind design affected negatively on the participation.</p> </list-item> <list-item id="lsti0020"> <label></label> <p id="par0020">65% of non-consenters declared that no trials should be conducted in children.</p> </list-item> <list-item id="lsti0025"> <label></label> <p id="par0025">Clinical trials' rationale and design need to be explained to the public.</p> </list-item> </list> </p> </sec> </abstract>